HEADER HYDROLASE/HYDROLASE INHIBITOR 16-APR-98 1A94 TITLE STRUCTURAL BASIS FOR SPECIFICITY OF RETROVIRAL PROTEASES COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEASE; COMPND 3 CHAIN: A, B, D, E; COMPND 4 EC: 3.4.23.16; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HUMAN IMMUNODEFICIENCY VIRUS PROTEASE, ROUS SARCOMA VIRUS PROTEASE, KEYWDS 2 PROTEIN-MEDIATED INTERACTION, VIRAL MATURATION, HYDROLASE-HYDROLASE KEYWDS 3 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.WU,J.M.ADOMAT,T.W.RIDKY,J.M.LOUIS,J.LEIS,R.W.HARRISON,I.T.WEBER REVDAT 6 07-FEB-24 1A94 1 REMARK REVDAT 5 03-NOV-21 1A94 1 REMARK SEQADV REVDAT 4 13-JUL-11 1A94 1 VERSN REVDAT 3 24-FEB-09 1A94 1 VERSN REVDAT 2 16-FEB-99 1A94 1 SOURCE COMPND REMARK KEYWDS REVDAT 2 2 1 HEADER REVDAT 1 13-JAN-99 1A94 0 JRNL AUTH J.WU,J.M.ADOMAT,T.W.RIDKY,J.M.LOUIS,J.LEIS,R.W.HARRISON, JRNL AUTH 2 I.T.WEBER JRNL TITL STRUCTURAL BASIS FOR SPECIFICITY OF RETROVIRAL PROTEASES. JRNL REF BIOCHEMISTRY V. 37 4518 1998 JRNL REFN ISSN 0006-2960 JRNL PMID 9521772 JRNL DOI 10.1021/BI972183G REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 100000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.1000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 86.1 REMARK 3 NUMBER OF REFLECTIONS : 20524 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.281 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.09 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 802 REMARK 3 BIN R VALUE (WORKING SET) : 0.2793 REMARK 3 BIN FREE R VALUE : 0.3083 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 0.12 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 94 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3024 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 118 REMARK 3 SOLVENT ATOMS : 181 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.014 REMARK 3 BOND ANGLES (DEGREES) : 2.130 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 27.07 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.700 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARACSDX.PRO REMARK 3 PARAMETER FILE 2 : PARAM19.SOL REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : TOPF19.SOL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1A94 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000170547. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NOV-96 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 4.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : R-AXIS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20944 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 8.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.1 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.08300 REMARK 200 R SYM (I) : 0.18200 REMARK 200 FOR THE DATA SET : 2.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.25 REMARK 200 COMPLETENESS FOR SHELL (%) : 76.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.08300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 4.7 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 1 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 30.85000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5410 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9190 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5450 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9180 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HH11 ARG B 57 HH TYR B 59 1.16 REMARK 500 H1 HOH A 701 O HOH A 727 1.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO D 79 C - N - CA ANGL. DEV. = 10.5 DEGREES REMARK 500 ASP E 25 CB - CG - OD1 ANGL. DEV. = 5.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 61 54.90 33.75 REMARK 500 GLU D 34 153.16 -48.63 REMARK 500 PRO D 79 48.14 -72.02 REMARK 500 GLU E 35 123.93 -33.63 REMARK 500 PRO E 79 53.61 -64.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 PEPTIDE INHIBITOR 0Q4 HAS A REDUCED PEPTIDE (-CH2-NH) INSTEAD REMARK 600 OF THE NORMAL PEPTIDE LINK (-CO-NH). REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: N-[(2R)-2-({N~5~-[AMINO(IMINIO)METHYL]-L-ORNITHYL-L- REMARK 630 VALYL}AMINO)-4-METHYLPENTYL]-L-PHENYLALANYL-L-ALPHA-GLUTAMYL-L- REMARK 630 ALANYL-L-NORLEUCINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 0Q4 A 100 REMARK 630 0Q4 E 100 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: ARG VAL DC0 GLU ALA NLE NH2 REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0Q4 A 100 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0Q4 E 100 REMARK 999 REMARK 999 SEQUENCE REMARK 999 MUTATIONS Q7K, L33I, L63I, C67A, C95A, HAVE BEEN MADE TO REMARK 999 STABILIZE THE PROTEASE FROM AUTOPROTEOLYSIS, WHILE REMARK 999 RETAINING ACTIVITY SIMILAR TO WILD-TYPE HIV-1 PROTEASE DBREF 1A94 A 1 99 UNP P03367 POL_HV1BR 69 167 DBREF 1A94 B 1 99 UNP P03367 POL_HV1BR 69 167 DBREF 1A94 D 1 99 UNP P03367 POL_HV1BR 69 167 DBREF 1A94 E 1 99 UNP P03367 POL_HV1BR 69 167 SEQADV 1A94 LYS A 7 UNP P03367 GLN 75 ENGINEERED MUTATION SEQADV 1A94 ILE A 33 UNP P03367 LEU 101 ENGINEERED MUTATION SEQADV 1A94 GLU A 43 UNP P03367 LYS 111 ENGINEERED MUTATION SEQADV 1A94 ILE A 63 UNP P03367 LEU 131 ENGINEERED MUTATION SEQADV 1A94 ALA A 67 UNP P03367 CYS 135 ENGINEERED MUTATION SEQADV 1A94 ALA A 95 UNP P03367 CYS 163 ENGINEERED MUTATION SEQADV 1A94 LYS B 7 UNP P03367 GLN 75 ENGINEERED MUTATION SEQADV 1A94 ILE B 33 UNP P03367 LEU 101 ENGINEERED MUTATION SEQADV 1A94 GLU B 43 UNP P03367 LYS 111 ENGINEERED MUTATION SEQADV 1A94 ILE B 63 UNP P03367 LEU 131 ENGINEERED MUTATION SEQADV 1A94 ALA B 67 UNP P03367 CYS 135 ENGINEERED MUTATION SEQADV 1A94 ALA B 95 UNP P03367 CYS 163 ENGINEERED MUTATION SEQADV 1A94 LYS D 7 UNP P03367 GLN 75 ENGINEERED MUTATION SEQADV 1A94 ILE D 33 UNP P03367 LEU 101 ENGINEERED MUTATION SEQADV 1A94 GLU D 43 UNP P03367 LYS 111 ENGINEERED MUTATION SEQADV 1A94 ILE D 63 UNP P03367 LEU 131 ENGINEERED MUTATION SEQADV 1A94 ALA D 67 UNP P03367 CYS 135 ENGINEERED MUTATION SEQADV 1A94 ALA D 95 UNP P03367 CYS 163 ENGINEERED MUTATION SEQADV 1A94 LYS E 7 UNP P03367 GLN 75 ENGINEERED MUTATION SEQADV 1A94 ILE E 33 UNP P03367 LEU 101 ENGINEERED MUTATION SEQADV 1A94 GLU E 43 UNP P03367 LYS 111 ENGINEERED MUTATION SEQADV 1A94 ILE E 63 UNP P03367 LEU 131 ENGINEERED MUTATION SEQADV 1A94 ALA E 67 UNP P03367 CYS 135 ENGINEERED MUTATION SEQADV 1A94 ALA E 95 UNP P03367 CYS 163 ENGINEERED MUTATION SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 A 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 A 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 A 99 GLY ARG TRP GLU PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 A 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 A 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 A 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 B 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 B 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 B 99 GLY ARG TRP GLU PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 B 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 B 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 B 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 D 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 D 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 D 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 D 99 GLY ARG TRP GLU PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 D 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 D 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 D 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 D 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 E 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 E 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 E 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 E 99 GLY ARG TRP GLU PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 E 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 E 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 E 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 E 99 GLN ILE GLY ALA THR LEU ASN PHE HET 0Q4 A 100 73 HET 0Q4 E 100 73 HETNAM 0Q4 N-[(2R)-2-({N~5~-[AMINO(IMINIO)METHYL]-L-ORNITHYL-L- HETNAM 2 0Q4 VALYL}AMINO)-4-METHYLPENTYL]-L-PHENYLALANYL-L-ALPHA- HETNAM 3 0Q4 GLUTAMYL-L-ALANYL-L-NORLEUCINAMIDE HETSYN 0Q4 INHIBITOR ANALOGUES OF CA-P2 FORMUL 5 0Q4 2(C40 H70 N11 O8 1+) FORMUL 7 HOH *181(H2 O) HELIX 1 1 ARG A 87 LEU A 90 1 4 HELIX 2 2 ARG B 87 ILE B 93 1 7 HELIX 3 3 ARG D 87 LEU D 90 1 4 HELIX 4 4 ARG E 87 LEU E 90 1 4 SHEET 1 A 4 GLN A 18 LEU A 23 0 SHEET 2 A 4 LEU A 10 ILE A 15 -1 N ILE A 15 O GLN A 18 SHEET 3 A 4 ILE A 62 ILE A 66 -1 N GLU A 65 O LYS A 14 SHEET 4 A 4 HIS A 69 GLY A 73 -1 N GLY A 73 O ILE A 62 SHEET 1 B 3 GLU A 43 GLY A 49 0 SHEET 2 B 3 GLY A 52 TYR A 59 -1 N GLN A 58 O GLU A 43 SHEET 3 B 3 VAL A 75 GLY A 78 -1 N VAL A 77 O ARG A 57 SHEET 1 C 4 GLN B 18 LEU B 23 0 SHEET 2 C 4 LEU B 10 ILE B 15 -1 N ILE B 15 O GLN B 18 SHEET 3 C 4 ILE B 62 ILE B 66 -1 N GLU B 65 O LYS B 14 SHEET 4 C 4 HIS B 69 GLY B 73 -1 N GLY B 73 O ILE B 62 SHEET 1 D 4 VAL B 32 GLU B 34 0 SHEET 2 D 4 VAL B 75 GLY B 78 1 N LEU B 76 O ILE B 33 SHEET 3 D 4 GLY B 52 TYR B 59 -1 N TYR B 59 O VAL B 75 SHEET 4 D 4 GLU B 43 GLY B 49 -1 N GLY B 49 O GLY B 52 SHEET 1 E 4 GLN D 18 LEU D 23 0 SHEET 2 E 4 LEU D 10 ILE D 15 -1 N ILE D 15 O GLN D 18 SHEET 3 E 4 ILE D 62 ILE D 66 -1 N GLU D 65 O LYS D 14 SHEET 4 E 4 HIS D 69 GLY D 73 -1 N GLY D 73 O ILE D 62 SHEET 1 F 4 VAL D 32 GLU D 34 0 SHEET 2 F 4 VAL D 75 GLY D 78 1 N LEU D 76 O ILE D 33 SHEET 3 F 4 PHE D 53 TYR D 59 -1 N TYR D 59 O VAL D 75 SHEET 4 F 4 GLU D 43 GLY D 48 -1 N ILE D 47 O ILE D 54 SHEET 1 G 4 GLN E 18 LEU E 23 0 SHEET 2 G 4 LEU E 10 ILE E 15 -1 N ILE E 15 O GLN E 18 SHEET 3 G 4 ILE E 62 ILE E 66 -1 N GLU E 65 O LYS E 14 SHEET 4 G 4 HIS E 69 GLY E 73 -1 N GLY E 73 O ILE E 62 SHEET 1 H 4 VAL E 32 GLU E 34 0 SHEET 2 H 4 VAL E 75 GLY E 78 1 N LEU E 76 O ILE E 33 SHEET 3 H 4 GLY E 52 TYR E 59 -1 N TYR E 59 O VAL E 75 SHEET 4 H 4 GLU E 43 GLY E 49 -1 N GLY E 49 O GLY E 52 SITE 1 AC1 25 ARG A 8 LEU A 23 ASP A 25 GLY A 27 SITE 2 AC1 25 ALA A 28 ASP A 29 ASP A 30 MET A 46 SITE 3 AC1 25 ILE A 47 GLY A 48 GLY A 49 PRO A 81 SITE 4 AC1 25 VAL A 82 HOH A 442 HOH A 511 ASP B 25 SITE 5 AC1 25 GLY B 27 ALA B 28 ASP B 29 ASP B 30 SITE 6 AC1 25 GLY B 48 GLY B 49 ILE B 84 HOH D1742 SITE 7 AC1 25 TRP E 6 SITE 1 AC2 29 TRP B 6 ARG D 8 LEU D 23 ASP D 25 SITE 2 AC2 29 GLY D 27 ALA D 28 ASP D 29 MET D 46 SITE 3 AC2 29 GLY D 48 GLY D 49 ILE D 50 PRO D 81 SITE 4 AC2 29 VAL D 82 ILE D 84 HOH D1767 ASP E 25 SITE 5 AC2 29 GLY E 27 ALA E 28 ASP E 29 ASP E 30 SITE 6 AC2 29 LYS E 45 MET E 46 ILE E 47 GLY E 48 SITE 7 AC2 29 GLY E 49 ILE E 50 PHE E 53 HOH E 438 SITE 8 AC2 29 HOH E1511 CRYST1 59.610 51.940 61.700 90.00 90.00 90.00 P 1 1 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016776 0.000000 0.000000 0.00000 SCALE2 0.000000 0.019253 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016207 0.00000